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Abstract: Cobalt porphyrin phospholipid (CoPoP) can incorporate within bilayers to enable non-
covalent surface-display of antigens on liposomes by mixing with proteins bearing a polyhistidine
tag (his-tag); however, the mechanisms for how this occurs are poorly understood. These were
investigated using the his-tagged model antigen Pfs25, a protein antigen candidate for malaria
transmission-blocking vaccines. Pfs25 was found to associate with the small molecule aquocobal-
amin, a form of vitamin B12 and a cobalt-containing corrin macrocycle, but without particle formation,
enabling comparative assessment. Relative to CoPoP liposomes, binding and serum stability studies
indicated a weaker association of Pfs25 to aquocobalamin or cobalt nitrilotriacetic acid (Co-NTA)
liposomes, which have cobalt displayed in the aqueous phase on lipid headgroups. Antigen inter-
nalization by macrophages was enhanced with Pfs25 bound to CoPoP liposomes. Immunization
in mice with Pfs25 bound to CoPoP liposomes elicited antibodies that recognized ookinetes and
showed transmission-reducing activity. To explore the physical mechanisms involved, we employed
molecular dynamics (MD) simulations of bilayers containing phospholipid, cholesterol, as well as
either CoPoP or NTA-functionalized lipids. The results show that the CoPoP-containing bilayer
creates nanodomains that allow access for a limited but sufficient amount of water molecules that
could be replaced by his-tags due to their favorable free energy properties allowing for stabilization.
The position of the metal center within the NTA liposomes was much more exposed to the aqueous
environment, which could explain its limited capacity for stabilizing Pfs25. This study illustrates
the impact of CoPoP-induced antigen particleization in enhancing vaccine efficacy, and provides
molecular insights into the CoPoP bilayer properties that enable this.
Keywords: molecular dynamics; simulations; bilayers; antigens; particles; vaccines; malaria
1. Introduction
Subunit vaccines formed from recombinant antigens hold potential for controlling
infectious diseases such as malaria [1]. Biomaterials that have structural versatility and
biocompatibility can be designed as adjuvants and antigen carriers to augment immune
responses [2–6]. Liposomes, which are self-assembling phospholipid bilayer vesicles, hold
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potential for vaccine adjuvants that also incorporate immunostimulant molecules, as has
been demonstrated with the clinical efficacy of the Adjuvant System 01 (AS01) and the
Army Liposome Formulation (ALF) formulations, for example [7]. They can improve
antigen delivery and presentation to antigen-presenting cells and improve immune cell
infiltration and maturation [8,9]. The adjuvant effect can benefit from physical or chemical
association of antigens through conjugation to vesicle surface or encapsulation within the
aqueous core [10]. The surface functionalization approach provides antigen accessibility
on the liposomal surface for antibody or B cell receptor recognition [11].
An incorporation strategy involving non-covalent attachment of antigens on the
surface of metallo-chelating liposomes using a polyhistidine tag (his-tag) as anchor allows
natural presentation of antigenic epitopes on the liposomal surface without chemical
modification [12]. Porphyrins are well-suited for metallochelation strategies [13]. One
unique strategy is exemplified by a liposomal vaccine platform containing cobalt porphyrin
phospholipid (CoPoP), of which the spatial location inside the hydrophobic bilayer is
thought to be responsible for improved his-tag protein binding stability in physiological
conditions, compared to nickel-chelating liposomes [14]. Spontaneous antigen attachment
to pre-formed CoPoP liposomes is thought to occur by insertion of a his-tag into the bilayer
membrane and subsequent coordination of the imidazole moiety to the metal center, while
the antigen itself is displayed on the liposome surface. While intuitively plausible, such
a mechanism has not been accounted for. From the physical point of view, one of the
main questions is how the his-tag accesses the bilayer interior since liposomes (especially
those used for drug delivery) can be tightly packed gel state with minimal access to the
membrane interior [15]. Here, we attempt to answer this question by coupling atomistic
MD simulations with experiments.
A recent study demonstrated the potent vaccine adjuvant effects of CoPoP/PHAD
(Phosphorylated HexaAcyl Disaccharide; synthetic monophosphoryl lipid A) liposomes
in inducing durable functional antibodies against Plasmodium falciparum surface protein
(Pfs25), a malaria transmission-blocking vaccine antigen candidate [16]. Previously, antigen-
engineering has been pursued to improve the induction of antibodies against Pfs25, includ-
ing the use of gold [17] or polymer [18] nanoparticles, and the use of virus-like particles
(VLPs) [19]. Other approaches make use of recombinant protein engineering for down-
stream Pfs25 multimerization [20] or attachment to VLPs [21]. The CoPoP system has been
demonstrated for other his-tagged antigens related to malaria transmission-blocking [22,23]
and other infectious diseases [24–26].
Vesicle size is a physical property that can play a role in the adjuvanticity of a par-
ticulate delivery system [27–30]. It affects clearance at the injection site, trafficking to
lymph nodes, and consequently downstream immune responses. This study investigates
the importance of particleization in cobalt tetrapyrrole immunization. Since CoPoP will
naturally form nanostructures in aqueous buffers, aquocobalamin (CblOH2), which is a
water-soluble tetrapyrrole macrocycle containing cobalt, was utilized to mimic the anti-
gen attachment method in a soluble and non-particleized form. The core macrocycle in
aquocobalamin is corrin, a porphyrin-related ring consisting of four reduced pyrrole rings
linked by three –CH = methylene bridges and one direct bond (Figure 1). We complement
experiments by performing MD simulations to study the differences in the microscopic
interactions in the CoPoP, solvated cobalamin and Co-NTA liposome systems.
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Figure 1. Cobalt tetrapyrroles and spectral shifts induced by imidazoles. Structure of aquocobala-
min (A) and cobalt porphyrin phospholipid (CoPoP) (B). Porphyrin and corrin rings are rendered 
in red. (C) Absorption spectra of aquocobalamin, cyanocobalamin, and CoPoP liposomes before 
and after incubation with imidazole or a his-tagged peptide. Spectral data shown are the averages 
of three independent scans. 
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2.1. Liposome Preparation and Characterization 
CoPoP liposomes composed of a mass ratio of 4:2:1 DPPC (Corden # LP-R4-057): cho-
lesterol (PhytoChol, Wilshire Technologies): CoPoP (synthesized as previously described 
[14]), prepared by ethanol injection and nitrogen-pressurized lipid extrusion. Extruded 
liposomes were dialyzed in phosphate buffered saline (PBS) at 4 °C to facilitate removal 
of ethanol and then were characterized by dynamic light scattering (DLS) using a Nano-
Brook 90Plus PALS instrument to measure liposome size and polydispersity index. CoPoP 
concentration was adjusted to 320 µg/mL by dilution. 
2.2. Absorption Spectra of Cobalt Tetrapyrroles 
Imidazole (Sigma-Aldrich, St. Louis, MO, USA, # I202) and his-tagged peptide (with 
the amino acid sequence SELLSLINDMPITNDQKKLMSHHHHHH with no internal his-
tidine residue, synthesized by Genscript) were incubated with hydroxocobalamin hydro-
chloride (Sigma-Aldrich # 95200), cyanocobalamin (Sigma-Aldrich # V2876), and CoPoP 
liposomes at a final concentration of 0.5 mM overnight at 4 °C. Pre- and post-incubation 
absorption spectra of aquocobalamin, cyanocobalamin, and CoPoP liposome were ac-
quired using Perkin Elmer UV-Vis spectrophotometer Lambda 365 at 0.5 nm intervals. 
2.3. Characterization of Histidine Binding to Cobalt Tetrapyrroles 
His-tagged Pfs25, prepared from a Baculovirus system as previously described [31], 
was diluted to 80 µg/mL and incubated with varying amounts of hydroxocobalamin hy-
drochloride. At the optimum binding ratio, hydroxocobalamin hydrochloride (320 
µg/mL) was incubated with 80 µg/mL Pfs25 at different time points and then subjected to 
Figure 1. Cobalt tetrapyrroles and spectral shifts induced by i idazoles. Structure of aquocobalamin
(A) and cobalt por hyrin phospholipid (CoPoP) (B . Porphyrin and corrin ri gs are rend re in red.
(C) Absorption spectra of aquocobalamin, cya ocobalamin, and CoPoP liposome before and after
incubation with imidazole or a his-tagged pepti e. Spectral data shown are the averages of three
independent scans.
2. Materials and Methods
2.1. Liposome Preparation and Characterization
CoPoP liposomes composed of a mass ratio of 4:2:1 DPPC (Corden # LP-R4-057):
cholesterol (PhytoChol, Wilshire Technologies, Princeton, NJ, USA):CoPoP (synthesized as
previously described [14]), prepared by ethanol injection and nitrogen-pressurized lipid
extrusion. Extruded liposomes were dialyzed in phosphate buffered saline (PBS) at 4 ◦C to
facilitate removal of ethanol and then were characterized by dynamic light scattering (DLS)
using a NanoBrook 90Plus PALS instrument to measure liposome size and polydispersity
index. CoPoP concentration was adjusted to 320 µg/mL by dilution.
2.2. Absorption Spectra of Cobalt Tetrapyrroles
Imidazole (Sigma-Aldrich, St. Louis, MO, USA, # I202) and his-tagged peptide (with
the amino acid sequence SELLSLINDMPITNDQKKLMSHHHHHH with no internal his-
tidine residue, synthesized by Genscript) were incubated with hydroxocobalamin hy-
drochloride (Sigma-Aldrich # 95200), cyanocobalamin (Sigma-Aldrich # V2876), and CoPoP
liposomes at a final concentration of 0.5 mM overnight at 4 ◦C. Pre- and post-incubation
absorption spectra of aquocobalamin, cyanocobalamin, and CoPoP liposome were acquired
using Perkin Elmer UV-Vis spectrophotometer Lambda 365 at 0.5 nm intervals.
2.3. Characterization of Histidine Binding to Cobalt Tetrapyrroles
His-tagged Pfs25, prepared from a Baculovirus system as previously described [31],
was diluted to 80 µg/mL and incubated with arying amounts of hydroxocobalamin hy-
drochlori e. At the optimum binding ratio, hyd oxocobalamin hydrochloride (320 µg/mL)
was incubated with 80 µg/mL Pfs25 at different time p ints and then subjected to native
electrophoresis using Tris-Glycine gel (Lonza, Bas l, Switzerland). Hydroxocobalamin
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acetate (Sigma-Aldrich # H8017) and cyanocobalamin were also incubated with Pfs25 for
comparison at 1:4 Pfs25:Cbl/CoPoP binding ratio. For peptide binding, a fluorescently
labeled peptide, FAM-RGD, was used and was previously demonstrated to bind to CoPoP
liposomes [14].
2.4. Cryo-Electron Microscopy (Cryo-EM)
CoPoP liposomes (320 µg/mL) were mixed with his-tagged Pfs25 (80 µg/mL) at an
equal volume ratio for 3 h at room temperature. The formulation also included PHAD
(320 µg/mL). Holey carbon grids (c-flat CF-2/2-2C-T) were washed with chloroform
overnight and glow-discharged at 5 mA for 15 s immediately before sample application.
Approximately 3.6 µL of the reaction mixture was deposited on EM grid. Vitrification was
performed using a Vitrobot (ThermoFisher, Waltham, MA, USA) by blotting the grids once
for 3 s and blot force +1 before they were plunged into liquid ethane. Temperature and
relative humidity in the Vitrobot chamber during the vitrification process were maintained
at 25 ◦C and 100%, respectively. Grids were loaded using a Gatan 626 single tilt cryo-holder
and introduced into a Tecnai F20 electron microscope (ThermoFisher) operated at 200 kV
and equipped with a Gatan K2 Summit direct detector device camera (Gatan, Pleasanton,
CA, USA). This detector was used in counting movie mode with five electrons per pixel
per second for 15 s exposures and 0.5 s/frame. This method produced movies consisting
of 30 frames with an exposure rate of ~1 e−/Å2. Movies were collected with a nominal
defocus of −2.5 µm and a nominal magnification of 25,000×, which produced images
with a calibrated pixel size of 1.45 Å. Motion correction for these images was done using
MotionCor2 [32]. Images were trimmed and prepared for figures using Photoshop (Adobe,
San Jose, CA, USA)
2.5. Fluorescence Quenching of Proteins and Peptides
Prior to labeling with DY-490-NHS-Ester (Dyomics, Jena, Germany, # 490-01), Pfs25
was dialyzed at 4 ◦C against sodium bicarbonate solution pH 9.0 at least twice. Stock
solution of the dye was added at five-fold molar excess to the dialyzed sample, followed
by stirring at room temperature for 2 h. Extensive dialysis against PBS was then performed
to remove any free dye. Post-dialysis protein concentration was quantified using a micro-
BCA assay. Liposomes (160 µg/mL CoPoP or CoNTA), or aquocobalamin (1600 µg/mL)
were incubated with FAM-RGD peptide or labeled protein (40 µg/mL), and fluorescence
measurements were acquired at excitation and emission wavelengths of 495 and 525 nm,
respectively, on a 5 nm bandwidth using TECAN Safire multi-plate reader. Percentage
fluorescence quenching was calculated by comparing to the free peptide or protein. Fetal
bovine serum (ThermoFisher # 10438026) was added to a final concentration as indicated.
2.6. Enzyme-Linked Immunosorbent Assay (ELISA)
Anti-Pfs25 IgG titers were estimated by ELISA. A 96-well plate (Thermo Scientific
Nunc, # 442404) was coated with 100 ng/well Pfs25, blocked with 2% bovine serum
albumin (BSA) in PBS containing 0.1% (w/v) Tween-20 (PBS-T), and incubated with mouse
serum serially diluted in 1% BSA in PBS-T. After incubation with horseradish peroxidase-
conjugated goat anti-mouse IgG secondary antibody (Genscript, Piscataway, NJ, USA, #
A00160), tetramethylbenzidine (Amresco, Dallas, TX, USA, # J644) was added. After color
development, 1M HCl was added to stop the reaction. Absorbance at 450 nm was acquired
using TECAN Safire multi-plate reader, (TECAN, Mannedorf, Switzerland). Endpoint titers
were defined as the reciprocal serum dilution that produced an absorbance cutoff of 0.5.
2.7. Antigen Uptake Study
RAW264.7 murine macrophage cells (ATCC, Manassas, VA, USA, # TIB-71TM) were
cultured in a 24-well plate in Dulbecco’s Modified Eagle’s Medium (DMEM, ThermoFisher
Scientific) containing 10% fetal bovine serum, 1% penicillin/streptomycin and grown to a
confluence of approximately 70–80%. Macrophage cells were incubated for 4 h at 37 ◦C
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with the indicated samples at a final concentration of 1 µg/mL DY-490-conjugated Pfs25.
Following incubation, macrophage cells were re-suspended in PBS and subjected to flow
cytometry using BD LSRFortessa X-20 flow cytometer. FlowJo (version 10, FlowJo, Ashland,
OR, USA) software was used for data analysis.
2.8. Murine Immunization
Animal experiments were conducted in accordance with the University at Buffalo
Institutional Animal Care and Use Committee (IACUC) regulations, protocol # BME05044.
Female eight-week-old CD-1® (ICR) mice received intramuscular (IM) injections containing
250 ng of Pfs25 combined with indicated adjuvants on days 0 and 21. Mouse sera were
collected on day 42. CoPoP liposomes were incubated with Pfs25 at 4:1 mass ratio of
CoPoP:protein for 3 h at room temperature prior to injection and diluted in PBS to achieve
the desired antigen dose for immunization. For Alhydrogel® adjuvant, 2% aluminum gel
(Accurate Chemical and Scientific Corporation, Westbury, NY, USA, # A1090BS), alum was
mixed with the antigen to a final concentration of 1.5 mg/mL.
2.9. Antibody Analysis
For Indirect Immunofluorescence Assay (IFA), P. falciparum ookinetes were obtained
from the midgut of Anopheles stephensi mosquitoes and fixed onto slides as previously
described [16]. After blocking with 5% BSA in PBS-T, slides were incubated with mouse
serum diluted 1/500 in 5% BSA in PBS at 37 ◦C for 1 hr and subsequently washed with
PBS in a humidity chamber for 5 min thrice. DyLight488-conjugated goat anti-mouse IgG
secondary antibody (ImmunoReagents, Raleigh, NC, USA, # GtxMu-003-F488NHSX) was
diluted 1/500 in 5% BSA in PBS and then incubated with slide for 30 min at 37 ◦C. Slides
were mounted with ProLong Gold Antifade with 4′,6-diamidino-2-phenylindole (DAPI,
Thermo Fisher Scientific # P36931) and imaged with an EVOS FL microscope using a 100×
objective lens. For Standard Membrane-Feeding Assay (SMFA), IgG was purified from
pooled mouse serum (n = 4) via protein G affinity chromatography (Pierce, Rockford, IL)
and mixed with a mature gametocyte culture of P. falciparum NF54 to a final concentration
of 0.75 mg/mL. Using a membrane-feeding apparatus, the final mixture was fed to female
Anopheles stephensi (Nijmegen strain) mosquitoes. After 8 days, the mosquitoes (n = 20 per
sample) were dissected to enumerate the oocysts in the midguts.
2.10. Molecular Dynamics Simulations
All-atom molecular dynamics (MD) simulations were carried out in an aqueous
solution. Four different systems were simulated: (1) water + cyanocobalamin, (2) water +
dipalmitoylphosphatidylcholine (DPPC) + cholesterol (termed pure bilayer here), (3) water
+ DPPC + Cholesterol + CoPoP (functionalized bilayer), and (4) water + DPPC + Cholesterol
+ NTA (functionalized bilayer). The cobalamin model used here has its basis on Marques
et al. [33] who used experimental data from 22 cobalamin structures including both cyano-
and aquoacobalamin. They noted that only the inclusion of complex alkyl ligands (R in
Figure 1A) required additional structural optimization of the bond properties. As Marques
et al. describes, the use of cyanocobalmin can be justified when structural properties
are the main interest. The bilayer models were generated using the CHARMM-GUI
Membrane Builder [34], and the CHARMM36 force field was used [35]. The CHARMM36-
compatible TIP3P water model was used for water [36,37]. All the systems were built in a
rectangular box containing a total of 512 lipids (256 per leaflet) with a hydration number
of 40 water molecules per lipid. The ternary systems were composed of 45% DPPC, 45%
cholesterol (CHL), and 10% of CoPoP or NTA. Partial atomic charges were computed with
an electrostatic potential (ESP) fitting approach. The MD simulations were carried out
using GROMACS 2018 package [38].
The systems were first energy minimized using the steepest descents algorithm fol-
lowed by six steps of equilibration runs. The first two steps composed simulations in the
constant number of atoms, volume, and temperature (NVT) ensemble and the remaining
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ones in the NPT (constant atoms, pressure, and temperature) ensemble. At least 400 ns
was used for the production runs in the NPT ensemble at 298.15 k and 1 bar. The V-
rescale thermostat was used for temperature coupling [39]. For pressure coupling, the
Parrinello–Rahman [40] method was used with semi-isotropic coupling. The simulations
were carried out using periodic boundary conditions (PBC) and the particle-mesh Ewald
(PME) method for electrostatic interactions [41]. A force-switch cutoff approach was used
for the Lennard-Jones potential over 1.0–1.2 nm. The Parallel Linear Constraint Algorithm
(P-LINCS) [42,43] algorithm was used to restrain the bond lengths. A time step of 2 fs was
used, and data were saved every 10.0 ps.
3. Results and Discussion
3.1. Experimental Results
Analogous to the porphyrin ring, the structure of cobalamins (vitamin B12) features a
central cobalt atom that is tightly coordinated to the four equatorial nitrogen donors from
the corrin ring (Figure 1A). The heterocyclic nitrogen atom of 5,6-dimethylbenzimidazole
occupies the lower α-axial fifth coordination site in the base-on configuration whereas
the upper β-axial position (sixth) may be occupied by various ligands, i.e., H2O in aquo-
cobalamin [44]. The axial β-ligand in aquocobalamin is exchangeable and hence can be
displaced by the imidazole group, which exhibits intermediate affinity [45,46]. This β-
ligand exchange in the octahedral complex allows attachment of Pfs25 to aquocobalamin
via coordinate bonding of the imidazole nitrogen of any histidine residue to the metal
center. Displacement of the aquo ligand by the histidine residue, however, is not exclusive
to the purification tag. Due to favorable accessibility in the upper plane of aquocobal-
amin, binding of any exposed histidine residue on the protein surface to aquocobalamin is
possible. In contrast, CoPoP binding necessitates a short segment of histidine residues to
facilitate insertion into the hydrophobic bilayer prior to coordination [14]. Importantly, the
mode of binding in aquocobalamin exemplifies a close representation of CoPoP binding
in aqueous medium. Moreover, the non-toxic nature of aquocobalamin eliminates the
possibility of any undesired side effects upon vaccination. IM injection of high doses of
cyanocobalamin did not elicit adverse reactions in humans [47].
Imidazole coordination to the cobalt center is reflected by the changes in the absorption
spectrum. Post-incubation absorption spectra for aquocobalamin, but not cyanocobalamin
(CblCN), revealed a spectral shift towards longer wavelength (Figure 1C). The red shift has
also been observed in a binding study with transcobalamin, an aquocobalamin-binding
protein [46]. The absence of a bathochromic shift in cyanocobalamin indicates that the
cyanide group was not substituted by imidazole, which is likely due to the strong metal–
carbon bond. Coordination of the imidazole to the metal center in CoPoP liposome results
in a bathochromic shift in absorption.
Association of Pfs25 to the aquocobalamin complex is associated with changes in the
electrophoretic migratory properties that arise from the small size increase and different
overall charge. Applying the same binding conditions to aquocobalamin resulted in an
optimum binding mass ratio similar to CoPoP (Figure 2A), which is 1:4 antigen:CoPoP/Cbl.
The 1:4 ratio of antigen: CoPoP when incubating Pfs25 with CoPoP liposomes was previ-
ously found to be required to ensure full protein binding [16]. Deviation from the expected
stoichiometry of the substitution reaction for aquocobalamin can be partly attributed to
the fact that hydroxocobalamin hydrochloride is a mixture of CblOH and CblOH2 under
physiological conditions [48].
Binding kinetics (Figure 2B) showed that binding of his-tagged protein to aquo-
cobalamin started to plateau about 3 h after incubation. Ligand substitution was also
observed for hydroxocobalamin acetate, an analog of hydroxocobalamin hydrochloride.
Cyanocobalamin with the tightly bound β-group displayed no apparent band shift in
native electrophoresis (Figure 2C), suggesting non-association of Pfs25. CoPoP and PoP
liposomes serve as positive and negative controls, respectively. Dynamic light scatter-
ing measurements depicted a slight increase in liposomal size and polydispersity after
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binding of Pfs25 (Figure 2D). The charge of these liposomes was previously shown to
be negative, before or after Pfs25 binding [16]. Cryo-electron micrographs indicate that
liposomal shape remains predominantly unaltered after binding (Figure 2E). Some CoPoP
liposomes, prior to protein binding, appeared to have a slight almond shape, for reasons
that are unclear. The 25 kDa size of the Pfs25 is too small to be directly visualized by cryo
electron micrographs.
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fluorescently-labeled Pfs25 was incubated with CoPoP lip somes, strong quench-
ing of the fluorescence was observed (Figur 3A). This is due to fluorescence energy transfer
f om the dye to the CoPoP in bilayer upon binding. In contrast, fluorescent quenching
of Pfs25 to CoNTA liposomes or aquocobalamin was limited. After 20% serum addition,
most of the quenching remained intact with Pfs25 bound to CoPoP liposomes. The small
amount of quenching was disrupted for CoNTA and aquoc balami . A ,
which is a small mole ule chro ophore, may be li ited to quench the fluorescently-labeled
protein relative to the dense CoPoP bilayer. The flu rescent quenc ing of Pfs25 bo nd to
CoPoP liposomes remained intact in varying conce ra ions of sera (Figure 3B). A similar
trend was observed with a fluorescently labeled peptide (Figure 3C), although the amount
of fluorescent quenching was gr ater with CoNTA and quocobalamin. This may be due
to the smaller size of the peptide and closer proximity of the fluorophore to the macrocycle.
With serum addition (Figure 3C), and in the presence of serum (Figure 3D), the quenching
was disrupted for CoNTA and aquocobalmin, but not for CoPoP. Competition might have
arisen from non-specific proteins in serum or cobalamin-binding proteins in serum such as
transcobalamin II [49]. Poor serum stability of the cobalamin-antigen and CoNTA complex
reflects weak association of the antigen through non-covalent interactions in the aqueous
mileu, suggesting the advantage of the sheltered antigen binding site in CoPoP liposome.
This is discussed further below in connection with MD simulations.
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An antigen uptake study was carried out using murine macrophages, as model antigen
presenting cells, using the fluorescently labeled antigen and flow cytometry with the gating
strategy shown in Figure S1 of the Supporting Information. While antigen uptake was
minimal when Pfs25 was in its free form, efficient cellular internalization was observed
when Pfs25 was liposome-bound (Figure 4). Given the instability of cobalamin-antigen
complex in serum, it was expected that Pfs25 uptake would be similar to that for the
free form. Likewise, minimal antigen internalization was observed for the non-chelating
PoP liposomes. High liposome internalization was obtained for PoP liposomes, but not
for CoPoP liposomes due to low fluorescence signal. To augment fluorescence of CoPoP
liposomes, CoPoP/PoP liposomes containing 1:1 ratio of CoPoP:PoP was produced. With
CoPoP/PoP liposomes, high antigen and liposome internalization were observed.
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Pfs25 is a sexual stage protein expressed on the surface of zygote and ookinete forms
of P. falciparum [50,51]. At 250 ng antigen dose, immunogenicity of three delivery plat-
forms of varying size was evaluated using enzyme-linked immunosorbent assay (ELISA)
(Figure 5A). Prime-boost immunization with Pfs25 bound to 100-nm liposomes on days 0
and 21 elicited an antibody titer on the order of 105, which is at least two orders of mag-
nitude higher than that for the micrometer-sized alum. Vaccination with aquocobalamin,
which is presumably less than 10 nm in size, failed to induce Pfs25-specific antibod-
ies. Immunofluorescence micrographs revealed that Pfs25-specific antibodies induced by
CoPoP liposome immunization can recognize surface epitopes on ookinetes (Figure 5B).
No apparent labeling of ookinetes observed for antisera raised against alum suggests low
levels of functional antibodies. Poor immunogenicity of aquocobalamin-bound Pfs25 is
substantiated by the absence of surface-labeled ookinetes.
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Figure 5. Immunogenicity of his-tagged Pfs25 and functionality of induced antibodies. (A) ELISA
titers following prime-boost vaccination of CD-1 mice with 250 ng of Pfs25 bound to indicated
samples. (B) Immunofluorescence assay of fixed P. falciparum ookinetes using goat anti-mouse IgG
(H + L) secondary antibody DyLight® 488 conjugate. Mice sera and secondary antibodies were both
diluted at 1:500. (C) Transmission-reducing activity based on oocysts intensity of pooled mouse sera
antibodies. Horizontal bars in (A,C) represent the geometric mean for n = 4 mice and the arithmetic
mean for n = 20 mosquito s, respectively. Average oocyst counts are i dicated above. Asterisks
denote statistical significance for the CoPoP group in (A) as assessed by one-way ANOVA with
Bonferroni multiple comparisons post-test comparisons of the log-transformed data and in (C) as
assessed by using a zero-inflated negative binomial model with Bonferroni correction; ** p < 0.01 and
**** p < 0.0001.
Malaria transmission-blocking vaccines based on Pfs25 work by inducing antibodies
that inhibit parasite development within the vector, Anopheles mosquitoes. Assessment
of transmission blocking activity of mouse sera antibodies induced by CoPoP liposome
vaccination by SMFA demonstrated the capacity of Pfs25-specific IgG antibodies to prevent
oocyst formation (Figure 5C). SMFA studies further showed no functionality of antibodies
from immunization with cobalamin-bound and alum-adsorbed Pfs25. Poor potency of
cobalamin-antigen complex, the non-particleized form, to induce functional antibodies
is probably due to its small dimension and loose antigen association. This highlights the
crucial role of particle stability in cobalt tetrapyrrole immunization.
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3.2. Simulation Results
Molecular dynamics (MD) simulations were used to examine the atomic-level mecha-
nisms that account for the observations that CoPoP could bind his-tagged antigens to form
stable particles, whereas Co-NTA and aquocobalamin could not. Four systems, a reference
bilayer with DPPC and Chol only, a CoPoP functionalized bilayer, an NTA functionalized
bilayer and cyanocobalamin in aqueous solution, were studied by MD simulations. The
CoPoP and NTA systems were used to examine the underlying microscopic mechanisms
and the cyanocobalamin system was used as a comparator. The last 10 ns of the 400 and
500 ns production runs were used for analysis. All systems were determined to be in
equilibrium by examining the convergence of the area per lipid versus time as well as other
structural and energy-based quantities following the protocols from previous studies by us
and others; see, for example, Reference [52].
Figure 6 shows configurations of cyanocobalamin and the CoPoP functionalized
bilayer at the end of the respective simulations. We used cyanocobalamin instead of
aquocobalamin (used in the experimental studies) for the following reasons: The difficulties
of parameterizing metal-containing molecules are extensively discussed by Pavlova et al.
whose recently developed CHARMM36-compatible force field cyanocobalamin is used
here [53]. The use of cyanocobalamin is justified since previous models show that the
structures of cyanocobalamin and aquocobalamin are similar, the ligand being the principal
difference [33,54]. Since we are not simulating chemical reactions but are interested in
structural information, using cyanocobalamin is a good choice and avoids unnecessary and
tedious force field parameterization. In addition, both the model used here [53] and the
previous parameterization by Marques et al. for the Amber force field that includes cyano-
and aquocobalamin (but is not compatible with CHARMM36, which is currently one of
the most accurate force fields for lipids) use a consensus structure for the corrin ring [33].
Snapshots of the NTA functionalized bilayer are displayed in Figure S4 in the Supporting
Information. Figure 6a shows a close-up of a cyanocobalamin molecule with its Co atom
indicated in pink for clarity. Figure 6b,c contains side and top views of the DPPC-Chol-
CoPoP system. Interestingly, the top view (Figure 6c) shows that the CoPoP molecules
(green) self-assemble to form a cluster; initially the CoPoP molecules were distributed
randomly. Although not immediately apparent in the figure, the number of cholesterols
inside the CoPoP cluster is depleted as compared to areas in which no CoPoP molecules are
present. This is illustrated in Figure S5 in the Supporting Information and we will return
to this later when we analyze the measurements below. We note that aquocobalamin was
used in the experimental studies whereas the simulations made use of cyanocobalamin as
a control, see the detailed discussion in section Materials and Methods.
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To gain a better view of how the CoPoP molecules behave, Figure 7a shows the
structures of the CoPoP rings in the bilayer and water molecules (red and white) that
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managed to penetrate the membrane and become proximal to the rings. Other molecules
are not shown for clarity. Interactions between the Co atoms and water molecules are an
important characteristic and analysis of the lifetimes of uninterrupted contacts between
these water molecules and the Co atoms shows that water molecules remain inside the
bilayer for extended periods of time, between 5 and 50 ps sometimes reaching up to 200 ps.
Notably, these times are the contact times and the actual residence times in the CoPoP
region are even longer.
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The hydrocarbon chains of the CoPoP molecules are shown in Figure 7b. The figure
indicates that two different populations are present: (1) well-ordered and (2) disordered
tails. The presence of disorder is a key property as will be elaborated below. Figure 7c
displays the relative positions of the DPPC and CoPoP headgroups. ost of the CoPoP
and PP head groups are al ost at the sa e height. To briefly summarize the central
observatio s in Figure 7: (1) ll the ater olecules that have penetrated the me brane
are either coordinated or are in the i ediate vicinity of the Co ato s (Figure 7a), (2) the
ring systems are clearly tilted away from the bilayer normal (Figure 7a), (3) the ydrocarbon
tails of the CoPoP molecules in the central part of the cluster ar disordere an ppear
to be in the liquid-disordered phase as compared to the gel phase of th DPPC molecules
(Figure 7b), and (4) the CoPoP molecules that are at the periphery of the clust r show
gel-like tai s as they have not yet been fully i tegrated into he cluster (Figur 7b). We now
analyze these properties quantitatively as d scussed below.
Starti fro the bilayer properties, t e area per lipid and bilayer thickness are
a ong the st o c aracteristics and t e re lc late si t TSLi [55]
program, which employs the Vor n i tessellation method for the ar a p r lipid. This allows
f r calculation of the areas per lipid for each of the c mponents as well as determination of
local thickness. For the refe ence syst ms (non-functionalized bilay rs), the component-
wise average reas per lipid are 0.36 ± 0. 1 nm2 and 0.45 ± 0.03 nm2 for CHL1 and DPPC,
respectively. These are in good agreement with the values reported in the literature [56–58].
Within the functionalized bilayer, these averages are 0.38 ± 0.01 nm2, 0.47 ± 0.01 nm2,
and 0.64 ± 0.02 nm2, for CHL1, DPPC, and CoPoP, respectively. Importantly, these results
show that unlike the rest of the bilayer, the area occupied by the CoPoP cluster (see
Figures 6b,c and 7b) is not in the gel phase. This conclusion is clear from the area per lipid
values as the values above indicate [57]. Thus, the CoPoP cluster forms a nanodomain
surrounded by the binary DPPC-cholesterol matrix that remains in the gel phase. It is
important to note that the CoPoP molecules were initially randomly distributed with their
hydrocarbon tails ordered (they were in the gel phase); as they cluster, they undergo a
transition to the liquid-disordered phase.
The presence of nanodomains provides a mechanism for water molecules to access
the bilayer core: The enlarged area per lipid and the tilted orientation of the CoPoP ring
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system allow for a small number of water molecules to penetrate into the bilayer and
to coordinate with the Co atoms as shown in Figure 7a,c. Previous studies have shown
that histidine inserts spontaneously into a DPPC membrane with a free energy minimum
below the lipid group [59]. It is, however, much harder for water to access the membrane
interior: Sapay et al. computed the free energies of insertion of a single water molecule into
various phospholipid membranes including DPPC and no minimum within the bilayer
was observed [60]. Importantly, this behavior can be controlled by lipid functionalization
and in our previous work we have shown that functionalizing the hydrocarbon chains
with porphyrin derivatives allows for controlling the amount of water that can access the
membrane interior in the membrane region that contains such modified lipids [61]. The
relevance of the current results together with the previous ones as discussed above can be
summarized as follows: CoPoP lipid functionalization leads to formation of nanodomains
in the lipid matrix and allows for a small number of water molecules to penetrate the
membrane. When histidines are present, they can, due to their favorable free energy inside
the membrane, easily replace the water molecules and coordinate with the Co atoms in the
CoPoP ring systems.
To analyze the local thickness of the bilayer, the normalized deviation from the average
z-position of the headgroup was computed. The aim of this analysis is to further examine
the character of the nanodomain with larger area per lipid: In the gel phase the lipid
tails are extended giving rise to a thicker membrane. Figure 8 shows that the normalized
deviation from the mean z-position may amount close to 50% of the height. The figure
shows the existence of a thinner area that corresponds to the CoPoP cluster while the rest
of the bilayer remains in the gel phase with much higher thickness. This analysis verifies
the conclusion of the co-existence of the gel and liquid-disorded phases as discussed above,
see also Figures S3 and S4 in the Supporting Information.
As discussed above, the CoPoP-rich domain has a larger area per lipid with disordered
tails. The larger area per lipid allows for some water molecules to penetrate inside the
bilayer. To quantify the behavior of the porphyrin rings, we analyzed their tilt angles. For
the water molecules to be able to remain inside the bilayer for extended times, they have to
form relatively stable contacts with the porphyrin ring systems that contain the Co atoms.
The analysis shows that the porphyrin rings are tilted on average by about 45◦ ± 5◦ with
respect to the bilayer normal (Figure 9a), thus allowing for the Co atoms to form strong
contacts with the water molecules. As discussed above, this provides an access point for
the histidine residues of the his-tagged protein to form a contact and coordinate with the
cobalt; the tilted orientation of the porphyrin rings is essential for this to occur. In addition,
the minimum distance between these water molecules and the Co atoms was determined to
be 0.45 ± 0.03 nm (Figure 9b), and the average number of water molecules at that distance
is 1.1 ± 0.2 (Figure 10) indicating significant hydration in the area where the Co atoms
are located.
The experimental data in this work confirmed that Co-NTA lipids were not as effective
as CoPoP with respect to serum stability. To assess the microscopic origin of this further, the
data from the simulations regarding the water contact sites of the NTA headgroups, which
are in the aqueous phase, were compared to the CoPoP cobalt site, which resides within the
bilayer. As shown in Figure 10, the NTA headgroups had a substantially greater number
of water contacts, 19.4 ± 0.5 at the distance of 0.45 nm compared to 1.1 ± 0.2 at the same
distance for CoPoP. Thus, in serum conditions, it is likely that (1) water surroundsthe NTA
headgroup and (2) serum proteins could compete and displace the his-tagged protein from
the NTA headgroups, whereas the CoPoP does not allow sufficient access and remains
serum stable.
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rophages was observed with the liposome-bound Pfs25 than with the non-associated 
forms. The particleized cobalt tetrapyrrole also induced higher immunogenicity than the 
non-particleized counterpart and alum. SMFA studies demonstrated that higher levels of 
functional antibodies can be induced with the cobalt tetrapyrrole in the liposomal form. 
We used atomistic MD simulations to establish the physical mechanism that accounts 
for the observed stability of the CoPoP systems. In our previous combined MD and ex-
perimental studies using porphyrin-based liposomes and membranes, we found that the 
rings of the porphyrin-based lipids were able to modify bilayer properties such that com-
pactness and access of water to the membrane interior could be controlled for controlled 
drug release and for better MRI contrast [61,62]. The situation here is analogous in the 
sense that the ring-like structures of the CoPoP lipids allow for a small number of water 
molecules to access the membrane interior. This is different from the NTA-functionalized 
bilayer, which had extensive contact with water in the headgroup region. Therefore, these 
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4. Conclusions
Stability of antigen attachment to metallo-chelating liposome based on cobalt por-
phyrin phospholipid i l t e bilayer is superior compared to that in the non-
particleized form or surfa e-chelated cobalt. As such, highe part cle i ternalization by
macrophages was observed with the liposome-bound Pfs25 it the non-as ociated
forms. The particleized cobalt tetrapyr ole also induced higher immunogenicity than the
non-particleized counterpart and alum. SMFA studies demonstrated that higher levels of
functional antibodies can be induced with the cobalt tetrapyrrole in the liposomal form.
We used atomistic MD simulations to establish the physical mechanism that accounts
for the observed stability of the oPoP syste s. In our previous combined MD and
experimental studies using porphyrin-based liposomes and membranes, we found that
the rings of the porphyrin-based lipids were able to modify bilayer properties such that
compactness and access of water to the membrane interior could be controlled for controlled
drug release and for better MRI contrast [61,62]. The situation here is analogous in the
sense that the ring-like structures of the CoPoP lipids allow for a small number of water
molecules to access the membrane interior. This is different from the NTA-functionalized
bilayer, which had extensive contact with water in the headgroup region. Therefore, these
MD simulations imply that the limited access to water in the CoPoP bilayer enables a
route for initial interaction with his-tagged proteins. This small amount of water contact
also may be appropriate for shielding the cobalt-his tag from competition with serum
proteins. From the physical point of view, the situation here is even more interesting as
the CoPoP-functionalized membranes show the presence of nanodomains with the matrix
being the gel phase and the nanodomain appears to be in the liquid-disordered phase.
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